Psychotic Disorders - Ukraine | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$31.02m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.30%, resulting in a market volume of US$33.10m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$96.19 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Ukraine is experiencing significant growth and development due to various factors.

Customer preferences: In Ukraine, there is a growing demand for effective treatments and therapies for psychotic disorders. Customers are increasingly seeking out medications and interventions that can alleviate symptoms and improve their quality of life. They are also looking for options that are affordable and accessible, as healthcare costs can be a burden for many individuals in the country. Additionally, there is a preference for treatments that have minimal side effects and are supported by scientific evidence.

Trends in the market: One of the key trends in the Psychotic Disorders market in Ukraine is the increasing availability and utilization of antipsychotic medications. These medications are commonly prescribed to manage symptoms of psychotic disorders such as schizophrenia. The market is witnessing the introduction of new and more advanced antipsychotic drugs, which offer improved efficacy and reduced side effects compared to older generation medications. This trend is driven by advancements in medical research and the growing understanding of the underlying neurobiology of psychotic disorders.Another trend in the market is the integration of psychosocial interventions alongside medication-based treatments. Psychosocial interventions, such as cognitive-behavioral therapy and family therapy, aim to address the psychological, social, and environmental factors that contribute to the development and maintenance of psychotic disorders. This holistic approach is gaining recognition and acceptance among healthcare professionals and patients alike, leading to increased demand for these interventions.

Local special circumstances: Ukraine has a high prevalence of mental health disorders, including psychotic disorders. This is partly due to the country's history of political and social instability, as well as the economic challenges faced by its population. The ongoing conflict in Eastern Ukraine has further exacerbated mental health issues, leading to an increased need for effective treatments for psychotic disorders.Additionally, the healthcare system in Ukraine is undergoing reforms to improve access to mental healthcare services. This includes efforts to increase the availability of specialized psychiatric clinics and the training of healthcare professionals in the diagnosis and treatment of psychotic disorders. These initiatives are contributing to the growth of the Psychotic Disorders market in the country.

Underlying macroeconomic factors: The economic development of Ukraine plays a significant role in the growth of the Psychotic Disorders market. As the country's economy continues to recover and stabilize, there is an increase in healthcare spending and investment in mental health services. This provides opportunities for the development and commercialization of new treatments and therapies for psychotic disorders.Furthermore, the government's commitment to improving mental health services and reducing the stigma associated with mental illnesses is driving the growth of the market. Efforts to raise awareness about psychotic disorders and promote early intervention are leading to increased diagnosis rates and treatment-seeking behavior among the population.In conclusion, the Psychotic Disorders market in Ukraine is experiencing growth and development due to increasing customer preferences for effective treatments, the emergence of new medications and psychosocial interventions, local special circumstances such as high prevalence of mental health disorders and ongoing healthcare reforms, and underlying macroeconomic factors such as economic development and government initiatives to improve mental health services. This presents opportunities for pharmaceutical companies and healthcare providers to meet the growing demand for treatments and interventions in the country.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.